1. A Thorough QTc Study Confirms Early Pharmacokinetics/QTc Modeling: A Supratherapeutic Dose of Omarigliptin, a Once‐Weekly DPP‐4 Inhibitor, Does Not Prolong the QTc Interval. Issue 5 (29th April 2016) Authors: Tatosian, Daniel A.; Cardillo Marricco, Nadia; Glasgow, Xiaoli Shirley; DeGroot, Bruce; Dunnington, Katherine; George, Laura; Gendrano, Isaias Noel; Johnson‐Levonas, Amy O.; Swearingen, Dennis; Kauh, Eunkyung Journal: Clinical pharmacology in drug development Issue: Volume 5:Issue 5(2016:Sep./Oct.) Page Start: 383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗